Catalyst Pharmaceuticals Logo

Catalyst Pharmaceuticals

🇺🇸
CPRX
US14888U1016

Catalyst Pharmaceuticals is a US-based pharmaceutical company dedicated to developing and commercializing innovative therapies for rare neuromuscular diseases. The company focuses on delivering much-needed medicines and enhancing the quality of life for patients globally by specializing in areas with high unmet medical needs.

Next Quarterly Earnings

Tuesday, November 3, 2026
Expected

Stock Price

Frequently asked questions

When did Catalyst Pharmaceuticals last report quarterly earnings?

Catalyst Pharmaceuticals last reported quarterly earnings on 5/11/2026 (Q1 2026). Earnings per share (EPS) came in at 0.50 USD.

How often has Catalyst Pharmaceuticals beaten expectations?

Catalyst Pharmaceuticals has beaten analyst EPS estimates in 4 of its last 4 evaluated quarters (beat rate: 100%).

How do I add the Catalyst Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Estimate:$0.74
Actual:
Q1 2026
Beat
Estimate:$0.45
Actual:$0.50
Difference:+$0.05
Q4 2025
Beat
Estimate:$0.34
Actual:$0.41
Difference:+$0.07
Q3 2025
Beat
Estimate:$0.54
Actual:$0.68
Difference:+$0.14
Q1 2025
Beat
Estimate:$0.54
Actual:$0.68
Difference:+$0.14

Earnings statistics

Estimates vs. results

4/4
Quarters above estimates
100%
Beat rate
+8.2%
Avg. EPS surprise

Basis: 4 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Catalyst Pharmaceuticals
Ticker Symbol
CPRX
ISIN
US14888U1016
Country
🇺🇸
USA
Sector